Novel Coronavirus Information Center

中文资源 (Chinese-language resources)

Welcome to Elsevier's Novel Coronavirus Information Center. Here you will find expert, curated information for the research and health community on SARS-CoV-2 and COVID-19.

All resources are free to access.

See our directory of all Elsevier's COVID-19 resources

For researchers

Under the Research tab, you can access early-stage and peer-reviewed research on COVID-19 from our journals, including The Lancet and Cell Press. We continue to add to the more than 112,000 COVID-related Elsevier journal articles and book chapters that are free to access on ScienceDirect and PubMedCentral

These articles are also available to download over FTP with rights for full text and data mining, re-use and analyses for as long as needed.

• Server address: coronacontent.np.elsst.com
• Protocol: sftp (SSH File Transfer Protocol)
• Username: public
• Password: beat_corona

You will need to use FTP client software such as Cyberduck or WinSCP to access the FTP server.

Download full text for data mining

We share daily updates to this corpus with the Allen Institute for inclusion in the multi-publisher CORD-19 dataset.

For clinicians

Under the Clinical information tab, you will find evidence-based skill guides and care plans for treatment, safety and patient education, along with emergency prepared resources.

For patients

In the Patient resources section, you can find our 3D4Medical coronavirus video, resources from the CDC and WHO, and information about Elsevier's Patient Access Program for research.

Share your feedback to help us improve our Novel Coronavirus Information Center. And if you experience any accessibility problems with the site or content, please contact accessibility@elsevier.com.

Vaccine guidelines

You can find more information on vaccines in Elsevier's COVID-19 Healthcare Hub Vaccine Toolkit:

• Clinical Overviews
• Nursing Skills
• Patient Education
• Patient Education videos
• Vaccines Blog

Podcast series

In Elsevier's podcast series for frontline clinicians and providers, experts share their insights into the mode of transmission and pathophysiology of the virus, how medical informatics and telemedicine are used to manage the pandemic, and best practices for emergency nursing crisis preparedness.

Anxiety resources

Anxiety screening tool

Elsevier has created this anxiety screening tool as part of our COVID-19 resources for patients, clinicians and the public. It's designed for individuals age 13 years and older. For all others, please talk to your healthcare team about you or your child’s questions and concerns.

More resources from Elsevier's Mental and Behaviorial Healthcare Hub

• Clinical Overview
• Drug information
• Nursing Skills
• Patient Education

Depression resources

Depression screening tool

Elsevier has created this depression screening tool as part of our COVID-19 resources for patients, clinicians and the public. It's designed for individuals age 18 years and older. For all others, please talk to your healthcare team about you or your child’s questions and concerns.

More resources from Elsevier's Mental and Behaviorial Healthcare Hub

• Clinical Overview
• Drug information
• Nursing Skills
• Care Plans
• Patient Education

Related stories by Elsevier book authors

Related articles freely available on ScienceDirect

Elsevier has made coronavirus-related articles and book chapters freely available for as long as is necessary, commencing in February 2020. This content is freely available on ScienceDirect and PubMedCentral

Additional resources include:

The Lancet Coronavirus Hub

The Lancet's Coronavirus hub page brings together new coronavirus content from The Lancet journals as it is published.

Cell Press Coronavirus Resource Hub

On this Coronavirus Resource Hub, curated by members of the Cell Press editorial team, you'll find  content about the outbreak as it appears in Cell Press journals along with our policies for submitting papers.

1Science Coronavirus Research Repository

1science, acquired by Elsevier in 2018, was created to expand the scope of existing abstracting and analytics databases. It includes quality controlled academic and research documents in all disciplines and languages, from all countries. Its core index, 1findr, currently comprises more than 120 million metadata records, including over 30 million links to free full-text articles selected from about 100,000 referred scholarly journals. The Coronavirus Research Repository is a custom extraction from 1findr comprising articles on COVID-19, MERS, SARS and coronaviruses in general.

Centre d’information sur le nouveau coronavirus

This French version of our Novel Coronavirus Information Center includes regular updates on research in French journals.

Content hubs from other publishers

Elsevier is among various publishers who are making relevant papers freely available. Others include: Springer Nature | Wiley | NEJM | BMJ | American Society for Microbiology | American College of Cardiology| Chongqing VIP Information. Many publishers have also signed the Wellcome Trust Statement committing to share relevant nCoV research and data rapidly and openly.

You can find all these publishers and more on LitCovid — the National Library of Medicine's curated hub of scientific literature about novel coronavirus. It currently provides access to more than 3,200 articles in PubMed and is being updated daily.

Early-stage research: preprints on SSRN

Rapidly evolving healthcare emergencies necessitate the quick dissemination of research. The growing role of preprints, or early-stage research, was acknowledged in the Ebola and Zika virus outbreaks as a way of “accelerating the dissemination of scientific findings to support responses to infectious disease outbreaks.” SSRN , Elsevier’s platform for the rapid worldwide dissemination of early-stage research, is committed to making authors' coronavirus related research available immediately. Research on SSRN is free to download and upload. It is important to note that these papers have not benefited from the pivotal role of the peer-review process, which validates and improves the quality of final published journal articles.

View coronavirus research on SSRN

Top 10 SSRN downloads of the week*

1. Efficacy of COVID-19 Vaccination on the Symptoms of Patients With Long COVID: A Target Trial Emulation Using Data From the ComPaRe e-Cohort in France 266
2. International Law of State Responsibility and COVID-19: an Ideology Critique 122
3. SARS-CoV-2 Antibody Response Following SPUTNIK V Vaccination in Healthcare Workers From a Hospital in Argentina: Preliminary Results 114
4. The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV) 47
5. Redesigning Widespread Insurance Coverage Disputes: A Case Study of the British and American Approaches to Pandemic Business Interruption Coverage 31
6. Last in Line: Vaccine Scarcity and the Americans with Disabilities Act 29
7. Voting Amid COVID: The Response of Voters to Voting during the Pandemic 27
8. State or Civil Society – What Matters in Fighting COVID-19? A Comparative Analysis of Hong Kong and Singapore 19
9. The Lived Experience of Health Insurance 18
10. Risks of Emergency Department Visits, Hospitalisations, Life-Threatening Events, and Deaths After SARS/nCoV2 Vaccination in the US: An Observational Study Using National Data 15

* Calculated on Friday, Oct 1, 2021

Infographic: Global research trends

Interactive map: global coronavirus experts

This map represents the most active institutions researching COVID-19 and related coronaviruses. We ran a search in Scopus — a source-neutral abstract and citation database of over 75 million records — for publications related to COVID-19, coronaviruses and related diseases such as SARS and MERS. We then used the resulting ~96,000 publications to identify the currently active researchers and institutions that are working in these areas, the map shows the most prolific global institutions and links to their authors. (Updated: September 8, 2021)

Click on a pin to see more about the institution, the numbers of researchers and their publications that matched our query in Scopus. Then link through to the researcher's profiles in Scopus to learn more about their areas of expertise.

The 15^th Vaccine Congress will take place online as a live-streamed and interactive event on October 4-6, 2021. The Congress is organized by Vaccine, the premier journal for those interested in vaccine science. Leading experts from around the world will join us online to share their knowledge on the current groundbreaking developments and discoveries in the field, including the frontrunner COVID vaccines.You will also have the opportunity to share and present your research and form new relationships with potential collaborators.

Register and submit proposals

COVID-19 drug therapy

You can find up-to-date information in Elsevier's Community Pharmacy Toolkit including:

• Drug monographs
• Patient Education

Drug information from Elsevier's R&D Solutions

Elsevier's R&D solutions for pharma and life sciences integrate data, analytics and technology to help researchers make data-driven drug discovery and development decisions and streamline literature monitoring for pharmacovigilance. Here, we use those tools to generate information relevant to combating COVID-19:

• Pathways depicting SARS molecular biology. These pathways were created to find protein targets for drug re-purposing against COVID-19. They were built by manually curating data extracted by Elsevier NLP from COVID-19 scientific articles and from their supplemental materials using Pathway Studio, which helps researchers analyze experimental data to understand the biological processes critical to their work.
• 121 drugs and natural products successfully used against previous coronavirus infections including SARS. This list was generated using Elsevier's Pathway Studio.
• 393 substances that interact with 25 targets related to 6 target species including SARS coronavirus, Middle East respiratory syndrome coronavirus, human Middle East respiratory syndrome coronavirus, Human coronavirus 229E, Coronaviridae and Coronavirinae, with normalized affinity value > 6. This list was generated using Elsevier’s Reaxys Medicinal Chemistry.
• Autophagy is a cellular recycling process, whereby cells eliminate damaged or diseased components in order to regenerate and build new healthier cells; thus, viruses are usually identified and disposed of in this way. Would it be possible to induce the autophagy process and limit the viral infection by using some substances? Pathway Studio provides a list of 406 compounds that have been reported inhibiting autophagy pathway, and their related references as well as a list of 802 compounds that have activating roles in autophagy.

Pure portal: Discover research collaborators and institutions globally

Use this Pure portal to discover novel coronavirus related research collaborators and institutions around the world. It uses Elsevier’s Natural Language Fingerprinting technology, scientific taxonomies and Scopus profiles and can be used to filter and find associated publications.

Additional information and examples

Gender and COVID-19 Group on Mendeley

This collection of research, studies and other references covers the sex and gender dimensions of the COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus. The library is a public group, free for anyone in the world to join, access and add. References – articles, preprints, news articles, blog posts, magazine articles, reports, etc – include those compiled by Dr. Rosemary Morgan at Johns Hopkins University and colleagues from the Gender and COVID-19 Working Group, as well as those from other compilations and sources. The library on the Mendeley platform includes >500 references related to Gender and COVID-19, as well as gender and other infectious disease/epidemics, which you can locate and find resources, include direct citations and references within your work, and add additional references & folders directly to the group. We invite the community to continue posting new references as they’re published/become available even if also being added to an existing compilation elsewhere.

COVID-19 Data Insights Map by LexisNexis Risk Solutions

By combining their data and analytics with those of other industry stakeholders, LexisNexis Health Care created a COVID-19 dataset and interactive visualization to provide insights on at-risk populations and care capacity risks. View the map

Special issue: Bioaerosol and infectious diseases

This special issue in the Journal of Aerosol Science, from 2018, has articles that are relevant to COVID-19.

Progress in Disaster Science: COVID-19 Special Collection

Keeping wider disciplinary involvement in mind, the journal Progress in Disaster Science plans to publish special issues as a major learning from the evolving nature of the pandemic. Papers on the following topics related to COVID-19 response are encouraged: public health response, governance and policy analysis, emerging technologies, roles of civil societies and other stakeholders, citizen participation, collateral hazards, business continuity, recovery planning, economic/fiscal implications. Read the special collection

Journal of Aerosol Science: Special section on "Virus Aerosol Science, Sampling, and Control"

The editor, Prof. Chris Hogan, writes: "The Journal of Aerosol Science has long been a resource on understanding viruses in aerosols, methods to sample airborne viruses, and to control and inactivate airborne viruses. In this collection, we highlight numerous studies over the past decade focusing on virus aerosol science. In addition, we invite authors to contribute this virtual collection by submitting to this journal, selecting the option: "SARS-CoV-2 & Virus Aerosols." Read the special section

COVID-19 podcasts and webinars by CIDRAP

Relevant webinars and audio podcasts by subject matter experts compiled by the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota. Each focuses on a different area of interest. View the list here

More public health resources

• Interactive map shows global spread of COVID-19 (Johns Hopkins CSSE)
• Information and updates (CDC)
• CDC vaccine guidance
• Travel health notices (CDC)
• Novel coronavirus advice for the public (WHO)
• Building a Resilient Recovery (OECD)
• Disaster Epidemiology and Surveillance, Chapter 27, Jekel's Epidemiology, Biostatistics, Preventive Medicine, and Public Health, 5th Edition (Elsevier, 2020)

Official guidance from various countries:

Argentina | Australia | Canada | Chile | China | Colombia | France | Germany | Mexico | Peru | Singapore | Spain | UK | US

عدوى فيروس كورونا المستجد (patient education in Arabic)

عدوى فيروس كورونا المستجد

Elsevier's Patient Access Program for research

With our Patient Access Program, patients and their caregivers can receive medical or healthcare related research papers by emailing patientaccess@elsevier.com. This email is constantly monitored by our support teams, who aim to provide individual articles at no cost to patients and caregivers within 24 hours. Requesters simply need to include the article title and authors, date published, and/or the DOI or URL if available so we can locate the article as quickly as possible. Learn more

COVID-19 podcasts and webinars

Relevant webinars and audio podcasts by subject matter experts compiled by the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota. Each focuses on a different area of interest. View the list here

More resources

• Novel coronavirus advice for the public (WHO)
• Travel precautions (CDC)
• See our Patient Education resources under Mental & Behavioral Health